Cystic fibrosis patients bearing both the common missense mutation Gly-- --Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus

Hamosh, A.; King, T. M.; Rosenstein, B. J.; Corey, M.; Levison, H.; Durie, P.; Tsui, L. C.; McIntosh, I.; Keston, M.; Brock, D. J.; Macek, M.; Zemkova, D.; Krasnicanova, H.; Vavrova,; Macek, M.; Golder, N.; Schwarz, M. J.; Super, M.; Watson, E. K.; Williams, C.; Bush, A.; O'Mahoney, S. M.; Humphries, P.; DeArce, M. A.; Reis, A.; Stuhrmann, M.; Schmidtke, J.; Wulbrand, U.; Dork, T.; Tummler, B.; Cutting, G. R.

Links

ORCID

Tools

Export citation

Search in Google Scholar

Cystic fibrosis patients bearing both the common missense mutation Gly-- --Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus

Journal article published in 1992 by A. Hamosh, T. M. King, B. J. Rosenstein, M. Corey, H. Levison, P. Durie, L. C. Tsui, I. McIntosh, M. Keston, D. J. Brock, M. Macek, D. Zemkova, H. Krasnicanova, Vavrova, M. Macek and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload